help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossi, F.
Right arrow Articles by Santiemma, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossi, F.
Right arrow Articles by Santiemma, V.
Endocrinology Vol. 143, No. 8 3096-3104
Copyright © 2002 by The Endocrine Society


ARTICLE

Angiotensin II Stimulates Contraction and Growth of Testicular Peritubular Myoid Cells in Vitro

F. Rossi, A. Ferraresi, P. Romagni, L. Silvestroni and V. Santiemma

Dipartimento di Fisiopatologia Medica, Università di Roma "La Sapienza" Facoltà di Medicina, 00161 Rome, Italy

Address all correspondence and requests for reprints to: Prof. Vittorio Santiemma, Dipartimento di Fisiopatologia Medica, V Clinica Medica, Policlinico Umberto I, Università di Roma "La Sapienza," Viale del Policlinico, 00161 Roma, Italy. E-mail: . vittorio.santiemma{at}uniroma1.it

Seminiferous tubule contraction, an important step in the regulation of spermatogenesis and testicular sperm output, is regulated by several agonists. In the present paper, we investigated whether angiotensin II (Ang II) may have a place among them.

In binding experiments performed to assess the presence of specific receptors in rat peritubular myoid cells (TPMC), binding of 125I-Ang II to TPMC was saturable in a time-dependent manner. Competition binding experiments performed with Losartan and PD 123319 showed that Losartan was able to inhibit the binding of 125I-Ang II, whereas PD 123319 was ineffective.

Ang II induced a dose-dependent rise in intracellular Ca2+. Depletion of intracellular calcium stores by thapsygargin resulted in a lower rise of intracellular calcium, and the L-type voltage-operated calcium channel (VOCC-L) blocker verapamil abolished the Ca2+ influx in rat TPMC. Altogether, these findings indicate that the Ang II-induced increase in [Ca2+]i involves both extracellular influx and Ca2+ release from intracellular stores.

Ang II induced a dose-dependent TPMC contraction, and Losartan and not PD 123319 inhibited the response. Ang II-induced contraction was inhibited by adrenomedullin, previously shown to antagonize endothelin 1-provoked contraction in those cells.

Ang II elicited 3H-thymidine DNA incorporation and proliferation in a dose-dependent manner in TPMC. Losartan and both MAPK inhibitor PD 98059 and tyrosine kinase inhibitor AG18 were able to inhibit Ang II-induced 3H-thymidine uptake and cell proliferation.

In conclusion, the present study documents that angiotensin II, the active mediator of the tissue and circulating renin-angiotensin system present in the mammalian testis, induces contraction, growth and rise in intracellular calcium in rat peritubular myoid cells via angiotensin II type 1 receptors, and suggests that Ang II is involved in the paracrine regulation of the seminiferous tubule function.




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Schell, M. Albrecht, C. Mayer, J. U. Schwarzer, M. B. Frungieri, and A. Mayerhofer
Exploring Human Testicular Peritubular Cells: Identification of Secretory Products and Regulation by Tumor Necrosis Factor-{alpha}
Endocrinology, April 1, 2008; 149(4): 1678 - 1686.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Hunyady and K. J. Catt
Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II
Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Karteris, J. Chen, and H. S. Randeva
Expression of Human Prepro-Orexin and Signaling Characteristics of Orexin Receptors in the Male Reproductive System
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1957 - 1962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society